ArticleBMC medicine2019

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.

Michael Berk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.